HCID 68157070, compound → HCID 178461934, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([N:9]2[C:13]3[CH:14]=[C:15]([F:18])[CH:16]=[CH:17][C:12]=3[N:11]=[C:10]2[C@@H:19]([NH:21][C:22]2[N:30]=[CH:29][N:28]=[C:27]3[C:23]=2[N:24]=[CH:25][N:26]3C2CCCCO2)[CH3:20])[CH:5]=[C:6]([F:8])[CH:7]=1>O1CCOCC1>[F:1][C:2]1[CH:3]=[C:4]([N:9]2[C:13]3[CH:14]=[C:15]([F:18])[CH:16]=[CH:17][C:12]=3[N:11]=[C:10]2[C@@H:19]([NH:21][C:22]2[N:30]=[CH:29][N:28]=[C:27]3[C:23]=2[N:24]=[CH:25][NH:26]3)[CH3:20])[CH:5]=[C:6]([F:8])[CH:7]=1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of {(S)-1-[1-(3,5-difluorophenyl)-6-fluoro-1H-benzoimidazol-2-yl]ethyl}-[9-(tetrahydropyran-2-yl)-9H-purin-6-yl]amine (137 mg, 0.28 mmol) in 4M HCL in dioxane (10 mL) was stirred for 1 h at RT. The reaction mixture was concentrated in vacuo, diluted with MeOH and loaded onto an Isolute® SCX-2 cartridge. The cartridge was washed with MeOH, followed by 2M NH3/MeOH. The basic fractions were combined and concentrated in vacuo. The resulting residue was purified by column chromatography (Si—PPC, gradient 2.5-10% 2M NH3 in MeOH/DCM) to afford 361 as a white solid (48 mg, 42%). LCMS (Method K): RT 3.65 min [M+H]+ 410. 1H NMR (CDCl3, 400 MHz): δ 12.87 (1H, bs), 8.09-7.94 (3H, m), 7.70 (1H, dd, J=9.0, 5.0 Hz), 7.40-7.38 (2H, m), 7.27-7.23 (1H, m), 7.11 (1H, ddd, J=10.0, 10.0, 2.5 Hz), 7.05-7.02 (1H, m), 5.71-5.61 (1H, m), 1.63 (3H, d, J=7.0 Hz)
Workup
- concentrationThe reaction mixture was concentrated in vacuo
- additiondiluted with MeOH
- washThe cartridge was washed with MeOH
- concentrationconcentrated in vacuo
- customThe resulting residue was purified by column chromatography (Si—PPC, gradient 2.5-10% 2M NH3 in MeOH/DCM)
Sources & evidence
- ORD record
- ord-02eeaba2bfc5424d9ed965ef1ddb0f99
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08653089B2
Reaction notes
Loading…